Overview
Revolade contains Eltrombopag 50 mg, a thrombopoietin receptor agonist used to treat low platelet counts (thrombocytopenia) in patients with conditions such as chronic immune thrombocytopenia (ITP), hepatitis C-associated thrombocytopenia, and aplastic anemia. It works by stimulating the production of platelets in the bone marrow, helping to reduce the risk of bleeding and bruising.





